These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 13802238)
41. Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions. Dumke CL; Kim J; Arias EB; Cartee GD J Appl Physiol (1985); 2002 Feb; 92(2):657-64. PubMed ID: 11796678 [TBL] [Abstract][Full Text] [Related]
42. [ANTIFIBRINOLYTIC ACTIVITY OF SOME BIOLOGICALLY ACTIVE POLYPEPTIDES]. BIANCHINI P Farmaco Sci; 1963 Oct; 18():763-72. PubMed ID: 14113063 [No Abstract] [Full Text] [Related]
43. Participation of the kallikrein-kinin-receptor system in reflexes arising from neural afferents in the dog epicardium. Staszewska-Woolley J; Woolley G J Physiol; 1989 Dec; 419():33-44. PubMed ID: 2576069 [TBL] [Abstract][Full Text] [Related]
44. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart. Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin. Spragg J; Vavrek RJ; Stewart JM Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073 [TBL] [Abstract][Full Text] [Related]
46. DETERMINATION OF BRADYKININ AND KALLIKREIN AS DIAGNOSTIC METHODS IN CARDIOVASCULAR DISEASE. OATES JA Listing Res Cardiovasc Field; 1964; 10():259-60. PubMed ID: 24547441 [No Abstract] [Full Text] [Related]
47. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat. Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455 [TBL] [Abstract][Full Text] [Related]
48. [The biological significance of bradykinin, as tissular hormone]. ROCHA E SILVA M Rend Ist Sup Sanit; 1960; 23():797-818. PubMed ID: 13742415 [No Abstract] [Full Text] [Related]
49. Alteration by kallikrein and bradykinin of the conversion of angiotensin I to angiotensin II in the isolated perfused rat lung. Ercan ZS; Bor NM; Torunoğlu M; Türker RK Arzneimittelforschung; 1982; 32(1):30-1. PubMed ID: 6174131 [TBL] [Abstract][Full Text] [Related]
50. Identification of porcine follipsin as plasma kallikrein, and its possible involvement in the production of bradykinin within the follicles of porcine ovaries. Kimura A; Kihara T; Okimura H; Hamabata T; Ohnishi J; Moriyama A; Takahashi K; Takahashi T Mol Reprod Dev; 2000 Sep; 57(1):79-87. PubMed ID: 10954859 [TBL] [Abstract][Full Text] [Related]
51. Synthetic bradykinin: its biological identity with natural pure trypsin bradykinin. KONZETT H; STUERMER E Nature; 1960 Dec; 188():998. PubMed ID: 13753030 [No Abstract] [Full Text] [Related]
52. FORMATION AND DESTRUCTION OF PLASMA KININS. FASCIOLO JC Acta Physiol Lat Am; 1964; 14():170-9. PubMed ID: 14185507 [No Abstract] [Full Text] [Related]
53. [On the clarification of the structure and synthesis of bradykinin]. KONZETT H Wien Klin Wochenschr; 1961 Feb; 73():119-20. PubMed ID: 13753033 [No Abstract] [Full Text] [Related]
54. A comparison in conscious and anaesthetized dogs of the effect on blood pressure of bradykinin, kallidin, eledoisin and kallikrein. Pearson L; Lang WJ Eur J Pharmacol; 1967 Nov; 2(2):83-7. PubMed ID: 5583434 [No Abstract] [Full Text] [Related]
55. URTICARIA: A REVIEW OF LABORATORY AND CLINICAL OBSERVATIONS. BEALL GN Medicine (Baltimore); 1964 Mar; 43():131-51. PubMed ID: 14132717 [No Abstract] [Full Text] [Related]
56. Increased plasma kallikrein activity and tumour growth suppression associated with intralesional bradykinin injections in hamsters. Koppelmann LE; Moore TC; Porter DD J Pathol; 1978 Sep; 126(1):1-10. PubMed ID: 722404 [TBL] [Abstract][Full Text] [Related]
57. Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release. Parthasarathy N; Torti SV; Torti FM Biochem J; 2002 Jul; 365(Pt 1):279-86. PubMed ID: 12071855 [TBL] [Abstract][Full Text] [Related]
58. Expression of kallikrein, bradykinin b2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta. Corthorn J; Germain AA; Chacón C; Rey S; Soto GX; Figueroa CD; Müller-Esterl W; Duarte I; Valdés G Endocrine; 2006 Jun; 29(3):491-9. PubMed ID: 16943589 [TBL] [Abstract][Full Text] [Related]
59. Human decidua is a target tissue for bradykinin and kallikrein: phosphoinositide hydrolysis accompanies arachidonic acid release in uterine decidua cells in vitro. Schrey MP; Holt JR; Cornford PA; Monaghan H; al-Ubaidi F J Clin Endocrinol Metab; 1992 Feb; 74(2):426-35. PubMed ID: 1309839 [TBL] [Abstract][Full Text] [Related]
60. Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat. Gáti T; Budavári I; Szombath D; Losonczy G Acta Physiol Acad Sci Hung; 1982; 60(4):213-8. PubMed ID: 6926659 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]